Patient flow. Median duration of treatment (N = 53); 12 cycles (range, 1-25). One cycle = 28 days. ASCT indicates autologous stem cell transplantation; CRd, carfilzomib, lenalidomide, dexamethasone; LEN, lenalidomide monotherapy; and SCC, stem cell collection.